Events & Press

Press Releases

30.01.2014

London, UK, 31st January 2014 NextPharma is pleased to announce that the US Food and Drug Administration (FDA) has completed a successful inspection of NextPharma’s centre of excellence for hormonal drug development and...

20.01.2014

NextPharma Technologies Holding Limited, a leading provider of contract development and commercial manufacturing services to the global pharmaceutical industry, today announced the appointment of two new Site Managers and a group...

29.07.2013

London, UK -NextPharma Technologies Holding Limited, a leading provider of contract development and commercial manufacturing services to the global pharmaceutical industry, is delighted to announce the appointment of outstanding...

26.07.2013

London, UK - NextPharma Technologies Holding Ltd, a leading provider of contract development and commercial manufacturing services to the global pharmaceutical industry, announced today the launch of its significantly expanded...

06.06.2013

NextPharma Technologies Holding Ltd announced today that Mitsubishi Pharma Europe (MPE), the European subsidiary of Mitsubishi Tanabe Pharma Corporation, has selected NextPharma as its fully-serviced outsourcing partner for the...

16.05.2013

London, UK, 16th May 2013 – NextPharma Technologies Holding Limited, one of the leading contract manufacturers in Europe for the pharmaceutical, biotechnology and healthcare industries, is delighted to announce the appointment of...

29.11.2012

London, UK, 29th November 2012 – NextPharma Technologies Holding Limited, one of the leading contract manufacturers in Europe for the pharmaceutical, biotechnology and healthcare industries, is pleased to announce the sale of...

Notes to Editors

About NextPharma

NextPharma, headquartered in the UK and founded in 2000, is a world class outsourcing partner to the pharmaceutical and biotechnology industry. 

The company:

Offers a full range of services from early phase product development, through clinical trial packaging (Phases I through III) to high volume commercial manufacturing. The company is a world leader in pellet technologies and in specialist product manufacturing including hormones, penicillins, and cephalosporins, in addition to providing manufacturing and packaging services for conventional product forms.  Additionally, NextPharma offers integrated logistics solutions tailored to meet the needs of the global pharmaceutical industry.

 

Operates globally with six product development centres, six manufacturing plants and six temperature controlled storage and distribution sites across Europe (production facilities in France and Germany), supplying customers in North America, Europe and the rest of the world.

 

Has 1,000 employees dedicated to serving over 150 customers worldwide.  Its customer base includes many of the world’s leading pharmaceutical, specialty pharma and biotech companies.